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  ABSTRACT
BACKGROUND: Post-operative nausea and vomiting 
(PONV) is a common complications   following general 
anaesthesia and is a leading cause of morbidity 
following surgery . The mainstay of management them 
is by the use of antiemetic. 
METHOD: It was a randomized double blind placebo 
controlled study. The sample size was calculated as 90 
from previous study with 10% attrition to make the 100. 
They were randomly divided into two groups; group B 
received dexamethasone prophylactically at induction 
while group A received placebo also at induction. All 
patients had balanced general anaesthesia and were 
taken to the recovery room postoperatively where 
incidences of postoperative nausea and vomiting were 
recorded. Patients with incidences of nausea and 
vomiting were treated with 10mg metoclopramide 
intravenously while postoperative complications that 
may be associated with dexamethasone prophylaxis 
were also noted.
RESULTS: The groups were comparable with respect 
to demographic characteristics.  More patients in group 
A(placebo group)) had incidence of nausea than group B 
(dexamethasone group) with p value of 0.01 and also 
more patients in group A had vomiting than group B with 
p value of 0.02; which was significant. The duration of 
stay in the recovery room for both groups A and B were 
however comparable with no statistical difference.
CONCLUSION: Dexamethasone when given 
prophylactically at induction reduces incidence of 
postoperative nausea and vomiting after gynaecological 
surgeries.
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INTRODUCTION                                       
Post-operative nausea and vomiting (PONV) is one of 
the commonest complications following general 
anaesthesia and is a leading cause of morbidity 
following surgery.  It can also result in morbidities such 
as wound dehiscence, bleeding, pulmonary aspiration of 
gastric contents, fluid and electrolyte disturbances, 
oesophageal tear (Mallory Weiss syndrome), delayed 
hospital discharge, unanticipated hospital admission 
following day case surgery, and patient dissatisfaction 
1
post surgery .  Studies and meta-analysis of PONV show 
high variability in PONV rates.  Overall incidences of 
1postoperative vomiting range from 12% -26% .. 
Dexamethasone is a synthetic glucocorticoid whose 
antiemetic mechanism is not known.  Dexamethasone 
prevents the development of the inflammatory process 
by suppression of neutrophil migration, decreased 
production of inflammatory mediators and reversal of 
2increased capillary permeability .There is no singular 
aetiology for PONV.  It is multifactorial in nature; 
however contribution of each factor may differ 
depending on the clinical situation. Some are related to 
patient factors, surgical procedures and/or the 
3anaesthetic technique used. It includes age; Amponsah  
in a study of postoperative nausea and vomiting in 
children between ages of a month and 16years reported 
4
the incidence to be 18 %.. Cohen et al  showed that 
incidence of vomiting is no doubt higher in paediatric 
age group when compared to adults. Women because of 
the high serum gonadotrophin level have three times the 
5risk for PONV compared to men . The risk of PONV is 
increased if anaesthesia is induced in a patient with 
recently ingested food and in those with delayed gastric 
6emptying . In obese patients, the larger adipose tissue is 
a reservoir for inhaled anaesthetic agents and may 
contribute to PONV even when their administration has 
1
been discontinued .
Patients with history of motion sickness and/or PONV in 
previous surgery are more susceptible to PONV than 
1those without history . Some factors predisposing to 
PONV that are surgical related includes the following 
conditions e.g. raised intracranial pressure, upper 
gastro-intestinal obstruction, pregnancy may be 
1
associated with PONV . The incidence of PONV after 
general anaesthesia is influenced by the type of surgical 
procedure, irrespective of the anaesthetic technique 
6used .   others includes duration of surgery, Oduntan et 
7al  in Ibadan reported that patients with surgery lasting 
for more than three hours had  a 5.1% incidence of 
PONV. Anaesthesia related factors predisposing to 
PONV includes opioids, inhalation agents notably 
halothane, nitrous oxide, neostigmine and intravenous 
induction agents like ketamine. The potential risk of 
PONV after regional technique is lower when compared 
to general anaesthesia except when intraoperative and 
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postoperative opioids are administered, and then the 
8
difference is narrowed .   
METHODOLOGY
This was a randomized double blind placebo control 
study over a 6 months period. Following approval of the 
hospital ethics committee consecutive patients aged 18-
65 years ASA 1 and 11 scheduled for elective 
gynaecological procedures under general anaesthesia 
were studied after signing informed consent. Patients 
requiring insertion of nasogastric tubes intra or 
postoperatively were excluded from the study. The 
sample size was calculated as 90 from previous study 
with 10% attrition to make 100.The patients were 
randomly assigned into two groups for the treatment of 
PONV by using table of random numbers. Group A 
received placebo (2mls of 0.9% normal saline), while 
group B received dexamethasone at a dose of 4mg/2mls. 
An anaesthesia resident and a pharmacist in the hospital 
prepared the medications in 2mls syringes, A containing 
2mls normal saline and B containing 2mls of 4mg of 
dexamethasone while the researcher was blinded. At 
induction of anaesthesia the contents of the labelled 
syringes were administered to patients by the researcher 
according to the alphabets A and B assigned to the 
patients.  All patients had balanced general anaesthesia 
and were transferred to the recovery room. 
Postoperative analgesia was with 100mg tramadol and 
the incidence of PONV was recorded in the first three 
hours postoperatively. Patients were discharged from 
recovery room when vital signs were stable and neither 
nausea nor vomiting was experienced.  Information on 
postoperative nausea and vomiting was also taken from 
patients using the questionnaire design. Patients were 
subsequently assessed by the blinded investigator with 
vomiting classified as mild if it is occurs once, moderate 
if the incidence is between one and three and severe if 
more than three.
Patients who experienced nausea and vomiting were 
treated with 10mg metoclopramide intravenously as a 
rescue medication, while postoperative complications 
resulting from dexamethasone prophylaxis were also 
noted.
STATISTICAL ANALYSIS
The data were analysed using Statistical Package for 
Social Sciences (SPSS) version 16 . Data description 
was by use of means and standard deviation for 
continuous variables; frequency and percentages for 
categorical variables. Measure of association was 
determined using the chi-square test for categorical 
variables and the ANOVA and student t test for 
continuous variables. Where appropriate data was 
presented using tables and bar charts.  A two sided p-
value of less than 0.05 was considered significant.
 RESULTS
One hundred patients participated in this study but four 
were disqualified for the following reasons: two had 
severe postoperative haemorrhage which required re-
exploration, one had failed intubation and surgery was 
cancelled while the fourth had severe hypertension 
postoperatively necessitating the use of hydralazine 
intravenously in the postoperative period.  Therefore 
only data from ninety six patients were analyzed.
 Assessment of incidence of nausea and vomiting
Patients in group A (placebo) had more incidence of 
nausea than those in group B (dexamethasone) 31 vs. 2 
(p =0.01).  Also group A had more incidence of vomiting 
than B; 27 vs 4 (p =0.02). 
TABLE 1: COMPARISON OF INCIDENCE OF 
NAUSEA BETWEEN STUDY GROUPS
TABLE 2: COMPARISON OF INCIDENCE OF 
VOMITING BETWEEN STUDY GROUPS
Assessment of severity of vomiting between study 
groups
 In group A, 25 patients had mild vomiting, one had 
moderate while none had severe vomiting while in 
group B only 4 patients had mild vomiting while none 
had moderate or severe vomiting (Table 3).
TABLE 3: COMPARISON OF SEVERITY OF 
VOMITING BETWEEN STUDY GROUPS
Comparison of surgical procedures between study 
groups
A total of 22 and 15 patients in groups A and B 
respectively had total abdominal hysterectomy while 
26(group A) and 33(group B) had myomectomy. The 
surgical procedures were comparable in both groups 
with no significant difference. (Table 4)
TABLE 4: COMPARISON OF SURGICAL 
PROCEDURES BETWEEN STUDY GROUPS
INCIDENCE OF NAUSEA GROUP A  GROUP B P value 
Incidence of nausea. Mean (%) 31(67.4) 2(4.2) 0.01 
 
INCIDENCE OF VOMITING GROUP A GROUP B P value
Incidence of vomiting. Mean (%) 27(57.4) 4(8.3) 0.02
SEVERITY GROUPA GROUPB P VALUE
NONE 22 44 0.001 
MILD           25 4 
MODERATE 1 0
SEVERE           0 0 
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TYPE OF SURGERY GROUP A GROUP B P VALUE
TOTAL ABDOMINAL HYSTERECTOMY 22 15 0.21
MYOMECTOMY 26 33 0.24
TOTAL 48 48  
Comparison of duration of surgery and stay in the 
recovery room 
Table 5 shows that the duration of surgery and duration 
of stay in the recovery room was comparable in both 
groups.
TABLE 5: COMPARISON OF DURATION OF 
SURGERY AND STAY IN THE RECOVERY 
ROOM
F I G U R E  1 :  B A R  C H A R T  S H O W I N G  
INCIDENCES OF NAUSEA AND VOMITING
DISCUSSION
This study has shown that dexamethasone is an effective 
prophylactic agent for postoperative nausea and 
vomiting in patients undergoing gynaecological surgery.  
From the onset of this study, a high incidence of PONV 
was anticipated considering the tetrad of female gender, 
gynaecological surgery and intraoperative use of 
halothane and tramadol, these being the predisposing 
2, 3, 4factors .   This setting was therefore provided to test 
clinical efficacy of dexamethasone in preventing PONV.  
The incidence of post operative nausea and vomiting 
was higher in the saline group than the dexamethasone 
group.  
9The above finding is in keeping with that of Guptal  et al 
10and Rimaitis et al in two different studies where they 
found the incidence of postoperative nausea and 
vomiting to be low in patients who had pretreatment 
with dexamethasone before gynaecological procedures.  
11
Zhang et al  also in their study that  investigated the 
incidence and influential factors of PONV following 
gynaecologic surgery  found out that previous PONV 
will increase the risk of recurrence . They also found out 
that perioperative opioids administration will intensify 
the risk for the development of PONV within 24hours 
following surgery, while general anaesthesia and 
postoperative shivering increases the risk within 6 hours 
after surgery.  
They concluded that perioperative dexamethasone 
decreases the incidence of PONV within 6hours or 
1224hours following gynaecologic procedures.  This is 
13, 14also in agreement with other multicentre studies  and a 
15systematic review  which demonstrated that this drug is 
effective in preventing PONV and also in patients 
16
receiving cancer chemotheraphy .
Several dose response studies have also been carried out 
to determine the minimum effective dose of 
dexamethasone needed for anti-emetic prophylaxis. The 
various peri-operative doses of dexamethasone that 
14have been tried so far are 2.5mg, 5mg, 4mg and 8mg . 
11 The last two doses are the commonly used hence the 
rationale for employing dose of 4mg in our study.  Kiu  
17
et al  in their  study observed 2.5 mg to be the minimum 
effective dose for preventing PONV in patients 
undergoing major gynaecological surgery, and in 
patients experiencing nausea and vomiting associated 
18  with epidural morphine . The timing of dexamethasone 
administration has been shown to have some association 
with its effectiveness as a prophylactic anti-emetic.  
 Wang et al observed that dexamethasone is most 
effective for preventing PONV when it is administered 
immediately before induction of anaesthesia rather than 
19  
near the end of anesthesia .  Our study like that of Wang 
pre-induction administration of dexamethasone had 
similar result like that of Thomas et al where 
20dexamethasone was administered after induction .
In this study a placebo was used as a comparator, but 
there exists the options of using either a contemporary 
standard drug and or placebo as a comparator.  Thomas 
et al argue that it is unethical to protect a group when all 
patients are actually exposed to the same high risk 
20procedure ; the risk here being nausea and vomiting.  
However one of the contemporary drugs in our setting 
that may be considered as a standard anti-emetic is 
21 12metoclopramide.  Beattie et al  and Huang et al  
independently found that metoclopramide is not 
effective as an anti-emetic at its current peri-operative 
dose of 10mg IV.  Henz and Tramer in one of their meta-
analysis also confirmed this but they say at this dose, it is 
22  
only effective as an anti-nauseant . They declared that 
metoclopramide is unfit to be used either as a control or a 
22
comparator in clinical trials .W Beattie in its editorial 
declared that until its effective peri-operative dose is 
determined, it cannot be considered a fair comparator in 
21
research trials .
Halothane was used as the maintenance agent because it 
is the most readily available inhalational agent in our 
DURATION 
OFSURGERY 
GROUP A GROUP B P value 
DURATION 
OFSURGERY 
2.72(0.23) 2.6(0.3) 0.08 
STAY IN RECOVERY 2.90(0.19) 2.84(0.28) 0.29
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environment, though it causes more emesis than 
Desflurane and sevoflurane which are not readily 
9
available .
Though tramadol an opioid was used as postoperative 
analgesic in the present study it could not have 
accounted for the high incidence of vomiting in the 
control group as both groups were given the same dose 
of tramadol.  A retrospective analysis of 492 patients  
who had gynaecological surgeries  identified history of  
PONV and peri-operative opioid administration as 
significant predictors of PONV within 24 hours 
11following gynaecologic surger .The analysis also found 
history of  PONV, general anaesthesia, and 
postoperative shivering  to be predictors of PONV 
within 6 hours of  surgery, and  the preoperative  
administration of dexamethasone  consistently 
protective against  PONV within 6 hours or 24 hours 
11following  gynaecological surgeries . 
This study did not identify any complication associated 
with dexamethasone use; it is in keeping with other 
studies that concluded that most of the complications 
following dexamethasone use occur as a late 
complication usually after 24 hours post surgery.  
Postoperative infection is one of the complications 
following use of dexamethasone though this was refuted 
 23
by Corcoran et al  where they were not able to 
demonstrate an association between anti-emetic doses 
of dexamethasone and postoperative infection in 439 
patients studied. The risk of postoperative infection 
could however not be ascertained with the present 
design because it is limited to only 3 hours postoperative 
period.
Other documented complications like headache, 
dizziness, drowsiness, constipation, sedation and 
23, 24
muscle pain  were not also observed in our study for 
similar reasons.
CONCLUSION
This study has shown that compared to placebo a single 
intravenous dose of 4mg dexamethasone given at 
induction of anaesthesia is clinically effective in 
preventing postoperative nausea and vomiting in 
women who had gynaecological   surgeries under 
general anaesthesia.  The incidence of postoperative 
nausea and vomiting was therefore high in those who did 
not have dexamethasone prophylaxis. It has also shown 
that dexamethasone prophylaxis does not increase the 
duration of stay in the recovery room.
RECOMMENDATIONS
Based on the finding from this study and some other 
multicenter studies that dexamethasone has clinically 
important peri-operative anti-emetic effects . Its use for 
prophylaxis against PONV in patients undergoing 
gynaecological surgeries under general anaesthesia 
should be encouraged. In addition it is cost effective and 
not associated with hangover effects . It can be given 
pre-induction  as an  anaesthetic premedicant or as an 
overnight dose since its biological half life is about 36-
1 5
72hours . No complication associated with 
dexamethasone was noted in this study, however since 
most of its complications occur latter than 3hours, a 
study with longer duration is recommended to ascertain 
this.
LIMITATION/STRENGTH OF THIS STUDY
Some of the limitations of this study include the study 
period (3hours) which only captured patients with early 
postoperative nausea and vomiting and the use of 
dexamethasone in patients who had regional anaesthesia 
were not studied . The incidence of PONV may have 
been higher than obtained if this period was more than 
3hours. Also most of the patients had difficulty in 
classifying the severity of nausea. Tramadol; a 
proemetic agent was used as analgesic for all patients 
thereby increasing the strength of this study in 
evaluating the effectiveness of dexamethasone in 
preventing PONV considering this pro-emetic milieu.
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